Overview
Novalix is a premier contract research organization, dedicated to improving the critical early stages of drug discovery by combining exceptional scientific talent and exclusive technology with a comprehensive portfolio of world-class chemistry, biophysics and pharmacology capabilities. We apply our exceptional scientific talent and exclusive resources across our platform to improve the odds of success at each critical pre-clinical stage. The better the science, the better the outcomes.
Our capabilities include:
– Medicinal chemistry
– Cheminformatics
– Synthetic chemistry
– Process chemistry and scale-up
– Biophysics: NMR, MS, SPR
– Protein production with expertise in GPCRs
– Structural biology: Cryo-EM, protein x-ray crystallography and NMR
– in vitro pharmacology
– in vivo pharmacology
– Translational science
– Biobanking
– Histology
– ADME-DMPK and pre-formulation
Experts in diverse modalities: small molecules, biologics (mAbs, ADCs), PROTACs.
Therapeutic areas: oncology, immuno-inflammation, infectious diseases, fibrosis, kidney, osteoarthritis, metabolic disorders.
Our facilities are located in France and Tunisia.
We operate business representative offices in the United States, Japan and Tunisia.